Market Tracker

07/31 6:05pm ET

TG Therapeutics Inc (NASDAQ:TGTX)

During the Trading Day
7.91 -0.26 / -3.18%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.89 -0.02 / -0.25%
 
Volume: 9.9K

Today’s Trading

Previous close8.17
Today’s open7.98
Day’s range7.73 - 8.07
Volume289,768
Average volume (3 months)479,523
Market cap$311.4M
Dividend yield--
Data as of 4:00pm ET, 07/31/2014

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)-58.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+699.98%
P/E ratioNM
Price/Sales650.44
Price/Book7.00

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd-0.09-1.60%
AMPEAmpio Pharmaceutical...-0.12-1.95%
XNCRXencor Inc+0.08+0.84%
PTXPernix Therapeutics ...-0.38-4.82%
Data as of 4:02pm ET, 07/31/2014

Financials

Last reporting dateJuly 21, 2014
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$152.4K
Annual profit (last year)-$20.5M
Net profit margin-13,438.82%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael S. Weiss
Chief Financial Officer, Treasurer &
Secretary
Sean A. Power
Corporate headquarters
New York, New York

Forecasts